Clinical trial of Guda Vati with tablet Doxophylline in Bronchial Asthma

An open labelled randomized controlled trial to evaluate the efficacy of Guda Vati with tablet Doxophylline in Tamakshwasa with special reference to Bronchial Asthma - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/101963

Enrollment

Registered

2026-01-23

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J453- Mild persistent asthma

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients having classical signs and symptoms of Tamakashwasa in Avegavastha and symptoms of mild to moderate nature. 2. Patients with known case of Bronchial Asthma having signs and symptoms of mild to moderate nature from more than one year. 3. PEFR more than 300 liters per min 4. Age: 19 to 60 Years. 5. Gender: Irrespective to gender

Exclusion criteria

Exclusion criteria: 1. Pregnant woman Lactating mothers . 2. Cardiac Asthma, Uncontrolled Diabetes Mellitus and Hypertension 3. Patients taking Inhaler daily will be excluded. 4. Patient of Tamakshwasa with secondary infections. Patient suffering from systemic disorders like Tuberculosis, Emphysema, Cor-Pulmonale, etc.

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of Guda Vati 1gm twice a day when compared with Tablet Doxofylline 200mg in reduction of symptoms of Tamakshwasa over the period of 21 daysTimepoint: base line 0 days, 7 days, 14 days, 21 days	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Rushikesh Vilas Lande

MAMs Sumatibhai Shah Ayurved College Hadapsar Pune

landerushikesh234@gmail.com7039626286

Outcome results